2014: Molecular Mechanisms of Poor Dietary Health
The Breakthrough Medical Discovery of Our Time
George A. Scheele. M.D.
This document details the breakthrough discoveries in science, medicine and dietary health that Dr. George A. Scheele has made over the past 45 years to explain the diet-related causes of metabolic disease that pervade our society and account for the overlapping epidemics of obesity, type 2 diabetes, lipid disorders and cardiovascular disease. When combined these discoveries explain the rapid increase in metabolic suffering observed in the advanced world over the past 35 years as well as the growing menace of poor health now observed in the underdeveloped world due to globalization of the food industry.
Based on Dr. Scheele’s invention of 2D gel electrophoresis in 1975, which provided the first high-resolution technique to monitor all the proteins in vertebrates, mammals and humans, now estimated at 20,000, and his subsequent nutritional studies conducted on laboratory animals and humans over the past three and a half decades, the following will serve as a partial list of innovative discoveries that explain the pathogenesis of metabolic disease associated with these overlapping epidemics.
Science and medicine have known for the past 60 years that higher animals, including humans can only produce 10 to 11 of the 20 amino acids required for protein synthesis. Earlier researchers called these “non-essential” amino acids because it is not essential that they be obtained from the diet. The remaining 9 to 10 amino acids are called “essential” because, since they cannot be produced by the organism, it is essential that they be provided in the diet. In the intervening period of time other investigators have not explored the potential deficiencies that may be inherent in the dichotomy of essential and non-essential amino acids in vertebrate and human biology.
With 45 years of dedicated scientific inquiry, Dr. Scheele has uncovered a long list of experimental discoveries related to diet-related deficiencies and their associated diseases. Each of the points summarized below relate to novel discoveries as Dr. Scheele was the first to:
- Demonstrate an unqualified deficiency in the movement of essential and positive-charged amino acids up the food chain to higher organisms, including man.
- Show that these deficiencies lead to selective deficiencies in positive-charged proteins, a condition that Dr. Scheele refers to as “Selective Protein Deficiency Syndrome.”
- Demonstrate the hierarchy in loss of diet-related protein expression, by up to 90-95% within 10-12 days, resulting in an imbalance in metabolic pathways.
- Hypothesize that poor dietary health, represented by high fat and carbohydrate diets deficient in protein, lead to chronic degenerative disease associated with the metabolic syndrome as exemplified by the overlapping epidemics of obesity and metabolic disease, including hypertension, type 2 diabetes, lipid disorders, cardiovascular disease, cancer, osteoarthritis, and gallbladder, liver & kidney disease, autoimmune diseases, and Alzheimer’s Disease.
- Show that closing the gap in the food chain by correcting for the deficiencies in positive-charged amino acids, proteins, and enzymes rebalances metabolic pathways.
- Demonstrate that this approach prevents, treats and/or cures obesity, type 2 diabetes, lipid disorders and cardiovascular disease.
- Use the hypothesis to identify the specific positive-charged proteins that appear to play a role in appetite stimulation (hyperphagia) and chronic degenerative diseases, including Obesity, Diabetes, Lipid Disorders, Cardiovascular Disease, Alzheimer’s Disease, Pancreatitis, and Liver Cancer.
- Explain why high protein foods and protein supplements, enriched in negative-charged proteins, serve as inefficient substrates to close the food chain gap.
- Show that essential amino acids and their metabolites act as key satiety agents to signal the appetite center of the brain (the Arcuate Nucleus or ARC) and the Hypothalamus that the organism is not only well fed but also healthy.
- Suggest that the diseases of aging are associated more with poor dietary health than aging.
By closing the food chain gap and correcting for deficiencies of essential nutrients in the diet, Dr. Scheele’s research has also shown how Factor4Weight Control® with Power Amino Acids® may be used to:
- Combat the overlapping epidemics of obesity, diabetes, lipid disorders and cardiovascular disease as well as a number of autoimmune disorders that compromise world health.
- Reduce health-care costs and therefore reduce the major causes of national budget deficits around the world.
- Increase national productivity by combating poor health, attitude and disease.
- Improve mental health, cooperation and attitude.
- Reduce dependency and addictive disorders.
- Improve national security by reducing the national deficit, improving the nation’s health, and enhancing the nation’s productivity.
George A. Scheele, M.D.
Dr. Scheele is a world-renowned physician, inventor, author and two-time Nobel Associate, who has pioneered in understanding the critical role of amino acids in regulating metabolic health and body weight. He recently introduced Factor4 Weight Control® with essential ingredients to treat the four nutritional traps that lead to overweight disorders and obesity.
As a graduate of Princeton University and Johns Hopkins Medical School he served as Professors of Medicine on the faculties of The Rockefeller University, Yale University School of Medicine and Harvard Medical School. Dr. Scheele invented new concepts and techniques which “cracked the code” in understanding how Power Amino Acids® correct the deficiencies in amino acids, positive-charged proteins, and metabolic pathways that normalize body weight and restore metabolic health.
A pioneer in the development of the fields of Cell Biology and Molecular Biology and their impact on understanding chronic human diseases, he participated in work that won two Nobel Prizes in Medicine awarded in 1974 and 1999.
As a leader in nutritional science and medical research with 40 years of innovative scientific research and 10 years of breathtaking achievements in the fields of obesity and metabolic disease, Dr. Scheele’s passion has always been to “Make the World a Better Place”. After moving to La Jolla in 1998, he has utilized his vast experience to develop superior health-care products for individuals living in today’s fast-paced world.
Dr. Scheele is currently the Founder, President, and CEO of NovaLife, Inc. a San-Diego based biotech company that has pioneered in the development of innovative health-care products for people who suffer from obesity and metabolic diseases, including diabetes, lipid disorders, cardiovascular disease, autoimmune disorders, and aging.
Confidential Document: All rights reserved. No part of this document may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any other information storage and retrieval system, without the written permission of the publisher.
Disclaimer: Factor4 Weight Control® is not meant to diagnose, treat, cure, or prevent any disease by the use of pharmaceutical drugs. As a dietary supplement, with all natural ingredients, considered to be “generally regarded as safe” (GRAS), Factor4 is intended only to improve health and wellness in the organs and tissues throughout the body. Comments and notations, derived from testimonials and limited human studies, have not been evaluated by the FDA. All results stated in these medical and scientific articles and on our website(s) are actual results from real customers or individuals included in our clinical trials. Individual results may vary depending on personal goals and use.